South Korean software provider Hyundai Mobis selected Israel's Cognata, a provider of simulation software and training data for driver-assistance systems and autonomous vehicles, to test its offerings.
Cognata noted that large-scale simulation provides the only environment where autonomous vehicle technology and advanced driver-assistance systems (ADAS) can be safely tested and validated.
The deal brings Cognata's technology to one of South Korea's largest automotive groups during an incredible momentum and growth in autonomous driving and ADAS in South Korea.
Lee Chang-ik, who manages autonomous vehicle simulation in Hyundai Mobis, said Cognata would accelerate their time-to-market offerings.
According to NH Investment & Securities analyst Cho Soo-hong, Hyundai Mobis should see mid to long-term earnings growth as a key automotive electronics provider for Hyundai Motor Group, set to introduce its E-GMP EV-dedicated platform in 2021.


California Drivers Sue BP, Walmart, 7-Eleven Over Alleged AI Gas Price Fixing
DOJ Opens Investigation Into NYC Coffee Shop Over Anti-Goldman Social Media Post
SpaceX Stock Rebounds After Sharp Selloff, But Valuation Concerns Persist
Trump’s Quantum Push Lifts IBM Stock as CEO Arvind Krishna Receives White House Praise
Alphabet Replaces Verizon in Dow Jones Industrial Average
WiseTech Global Denies Knowledge of Investigation Into Founder Richard White
Tesla and NatPower Partner on $5 Billion Battery Storage Expansion in Europe
Cerebras Revenue Forecast Tops Expectations, but Margin Concerns Weigh on Stock
Samsung Electronics Stock Surges on Report of Massive $59 Billion Share Buyback Plan
Meta Pauses Employee Activity Tracking Program Over Data Security Concerns
Nissan Halts Electric Qashqai Development Amid EV Market Challenges
Nike CFO Shake-Up Fuels Concerns Over Turnaround Strategy
SpaceX Stock Plunges 16% as KeyBanc Warns Valuation May Be Overstretched
Apollo Debt Solutions Limits Redemptions as Withdrawal Requests Surge
JPMorgan Sees Strong Strategic Value in Potential AbbVie Acquisition of Apogee Therapeutics
Tencent Reviews Marvelous Stake as Gaming Giant Reassesses Global Investment Strategy 



